A simple tool for monitoring nebulized amikacin treatments based on a single urine assay.

Faurisson, F; Delatour, F; Jelazko, P

Faurisson, F; Delatour, F; Jelazko, P.

Affiliation

Faurisson F; INSERM EMI-V 99 33, Hjpital Bichat Claude Bernard, Paris, France. faurisso@bichat.inserm.fr

J Aerosol Med ; 14(1): 73-81, 2001.

Article in En | MEDLINE | ID: mdl-11495488

Subject(s)

Amikacin/administration & dosage; Amikacin/urine; Cystic Fibrosis/drug therapy; Drug Monitoring/methods; Pneumonia, Bacterial/drug therapy; Pseudomonas Infections/drug therapy; Administration, Inhalation; Adult; Creatinine/urine; Cystic Fibrosis/microbiology; Female; Humans; Male; Middle Aged; Nebulizers and Vaporizers; Pneumonia, Bacterial/microbiology; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 4_TD Database: MEDLINE Main subject: Pseudomonas Infections / Amikacin / Drug Monitoring / Pneumonia, Bacterial / Cystic Fibrosis Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Aerosol Med Year: 2001 Document type: Article

Search on Google

XML

PubMed Links